PharmaCyte Biotech (PMCB) Gains (Losses) on Sale of Assets & Investments (2009 - 2026)
PharmaCyte Biotech's Non Operating Investment Income came in at -$154,548 for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$104,463 a year earlier.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Gains (Losses) on Sale of Assets & Investments (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, PharmaCyte Biotech reported Non Operating Investment Income of -$462,391; for FY2026 (ended Apr 30, 2026), it came in at -$412,306.
- Going back by fiscal year, Non Operating Investment Income was -$2.02 million in FY2025 and -$1.57 million in FY2024.
- The fiscal Q1 2027 figure represents the lowest quarterly Non Operating Investment Income since fiscal Q4 2025.
- Business Quant data shows PMCB's Non Operating Investment Income at -$118,241 (Q4 2026), -$128,939 (Q3 2026) and -$60,663 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | -154,548.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -154,548.00 |
| Apr 30, 2026 | -118,241.00 |
| Jan 31, 2026 | -128,939.00 |
| Oct 31, 2025 | -60,663.00 |
| Jul 31, 2025 | -104,463.00 |
| Apr 30, 2025 | -2.09 Mn |
| Jan 31, 2025 | 72,632.00 |
| Apr 30, 2024 | -1.57 Mn |
| Jan 31, 2010 | 57,692.00 |
| Jul 31, 2009 | -55,000.00 |
| Apr 30, 2009 | -2,800.00 |
| Jan 31, 2009 | 11,933.00 |
API Access
PharmaCyte Biotech Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();